Cart
sales@molnova.com
SU5204
CAS No. 186611-11-0
SU5204( 3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one )
Catalog No. M22955 CAS No. 186611-11-0
SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 30 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 42 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 177 | In Stock |
|
| 200MG | 259 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU5204
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
-
DescriptionSU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
-
In Vitro——
-
In Vivo——
-
Synonyms3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR2|HER2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number186611-11-0
-
Formula Weight265.31
-
Molecular FormulaC17H15NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (376.92 mM)
-
SMILESO=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peng Cho Tang, et al. 3-heteroaryl-2-indolinone compounds for the treatment of disease. US5792783A.
molnova catalog
related products
-
Tivozanib hydrochlor...
Tivozanib hydrochloride hydrate (AV-951 hydrochloride hydrate) is an orally active, selective, and potent vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor that inhibits VEGFR-1, VEGFR-2, and VEGFR-3.
-
PKI-166
PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.
-
Regorafenib hydrochl...
Regorafenib hydrochloride (BAY73-4506) is a potent, orally active multikinase inhibitor.
